The Series B funds will support the launch of a Phase I/II clinical trial for AIR-001 to advance its RNA editing pipeline.

The results of a study that identified the pathological mechanism of spinal stenosis and the target gene for treatment ...

A team developed the catGRANULE 2.0 ROBOT, a machine-learning algorithm to predict protein behavior linked to ...

Stoke Therapeutics, Inc. is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen ...

A research group led by Gian Gaetano Tartaglia, Principal Investigator at the Italian Institute of Technology (IIT ...

Under the right conditions, duckweed essentially farms itself. Wastewater, ponds, puddles, swamps—you name it. If there's ...

A Stanford study shows that tiny electrical charges in water droplets caused reactions that developed organic matter from inorganic materials.

Unlike animals, plants do not possess an adaptive immune system with antibodies or T cells to fight viral infections. Instead ...

Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a ...

Colorectal cancer is a serious but preventable disease if detected early. Advances in diagnostics, such as biomarker analysis ...

Gennova Biopharmaceuticals Ltd. on Tuesday announced that it is partnering with the Coalition for Epidemic Preparedness Innovations (CEPI), a subsidiary of Emcure Pharmaceuticals Ltd. for the ...